欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IS/H/0569/002
药品名称Nintedanib Teva B.V.
活性成分
    • nintedanib esilate 150.0 mg
剂型Capsule, soft
上市许可持有人Teva B.V., Swensweg 5, 2031 GA Haarlem, The Netherlands
参考成员国 - 产品名称Iceland (IS)
Nintedanib Teva
互认成员国 - 产品名称
    • Ireland (IE)
    • Austria (AT)
    • Portugal (PT)
    • Hungary (HU)
      Nintedanib ratiopharm 150 mg lágy kapszula
    • Croatia (HR)
许可日期2024/07/24
最近更新日期2025/01/27
药物ATC编码
    • L01EX09 nintedanib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase